Opportunities and exploring the impact of patient involvement in HTA
The aim is to help ALAN to compare opportunities for patient involvement in Health Technology Assessment (HTA) across countries and explore its impact.
This could be useful to enable ALANs member organisations to identify what opportunities there are for them to contribute to HTA in their own country, to lobby for changes (i.e. if there are limited opportunities in their country versus others) and to learn what may be most effective in influencing HTA. This latter point is however uncertain given the broader challenges in disentangling the influence of patient involvement on HTA recommendations (more on that later in this proposal).
There may be also opportunities to leverage the research in the context of Joint Clinical Assessments as part of the new HTA regulation in Europe, in force from January 2022, but due to be implemented in January 2025.